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Mouse embryonic ﬁbroblasts (MEFs) are commonly grown in cell culture and are known to enter senescence after a low number
of passages as a result of oxidative stress. Oxidative stress has also been suggested to promote centrosome disruption;
however, the contribution ofthisorganelle to senescence is poorly understood.Therefore, thisstudy aimed to assessthe role of
the centrosome in oxidative stress induced-senescence using MEFs as a model. We demonstrate here that coincident with the
entry of late-passage MEFs into senescence, there was an increase in supernumerary centrosomes, most likely due to
centrosome fragmentation. In addition, disrupting the centrosome in early-passage MEFs by depletion of neural precursor cell
expressed developmentally downregulated gene 1 (NEDD1) also resulted in centrosomal fragmentation and subsequent
premature entry into senescence. These data show that a loss of centrosomal integrity may contribute to the entry of MEFs into
senescence in culture, and that centrosomal disruption can cause senescence.
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Cells normally possess stringent checkpoint mechanisms to
ensure that they do not replicate with damaged DNA or other
cellular abnormalities. These checkpoints often manifest as
cell-cycle arrest, wherein defective cells are either repaired or
eliminated.
1 However, under certain culture conditions and in
responsetoparticularformsofstress,cellsentersenescence,
a state of irreversible growth arrest in the G1 to S phase
transition of the cell cycle,
2 and can remain metabolically
active for long periods of time.
3 In addition to proliferation
arrest, some senescent cells become resistant to apoptotic
death and most show morphological and metabolic changes,
including cellular enlargement, increased lysosome biogen-
esis and atypical senescence-associated b-galactosidase
activity (SA-b-gal).
4
Senescence can be triggered by many events including
DNA damage, telomere shortening, cell culture or oxidative
stress, cytotoxic drugs, overexpression of tumor suppressor
genes such as p53, or as a protective cellular response to
strong mitogenic signaling by oncogenes.
5–10 As the centro-
some is the primary microtubule-organizing center of the cell
andisthereforecriticalforcorrectcell-cycleprogression,
11itis
likely that defects in this organelle can also have a role in
senescence. Indeed, although disruption of the centrosome
has been shown to cause cell-cycle arrest, it can also
predispose cells to undergo senescence.
12,13 Whether the
centrosome is also involved in senescence caused by other
factors, such as oxidative stress, remains unknown.
Mouse embryonic ﬁbroblasts (MEFs) are commonly used
as a model to study cellular senescence. These cells senesce
as a result of oxidative stress in culture, which causes
extensive DNA damage and resembles hydrogen peroxide-
induced senescence in human cells, relying predominantly on
the activation of p53 and p19
ARF pathways.
14,15 To determine
whether the centrosome contributes to senescence in MEFs,
this study analyzed protein encoded by neural precursor cell
expressed developmentally downregulated gene 1 (NEDD1),
as a marker for the centrosome during senescence. This
protein is important in the targeting of g-tubulin to the
centrosome and is therefore essential for correct centrosomal
function.
16–19 This study showed that the entry of MEFs into
senescence was coincident with an accumulation of centro-
someabnormalities.Importantly,disruptingthecentrosomein
early-passage MEFs induced a loss of centrosome integrity
and led to premature senescence, suggesting that centro-
somes are involved in MEF senescence.
Results
MEFs enter senescence in culture after passaging.
MEFs were used as a model system for cells that grow for a
ﬁnite number of divisions in cell culture before entering
senescence. In multiple experiments using different batches
of cells, MEFs proliferated until passage 5–6, after which
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www.nature.com/cddistime their population doubling time was dramatically
increased (example shown in Figure 1a). The population
doubling time of these cells at passage 6 was B320h as
opposed to cells from passage 1 doubling every 28h. After
passage 6, the surviving cells recovered and the doubling
time decreased again (data not shown). This is likely due to a
population of cells escaping senescence and proliferating
again as a result of spontaneous immortalization, a
characteristic of MEFs in culture.
20 However, this study
only analyzed cells until the majority of the population ﬁrst
entered senescence (passage 6). To conﬁrm that these cells
were indeed entering senescence, a b-galactosidase assay
was performed to stain cells that express SA-b-gal activity.
4
Correlating with the doubling time, it was evident that the
majority of cells were senescent at passage 6 (Figure 1b). In
addition, the protein levels of p16, p19 and p21, which are
known to be associated with senescence, were also
analyzed. Expression of all of these proteins was increased
from about passage 3, and stayed high as the cells entered
senescence (passage 6) (Figure 1c). The level of p21 mRNA
transcript was analyzed using quantitative real-time PCR
(qPCR). This correlated well with the protein expression, as
p21 mRNA was increased at passage 4 and again at
passage 6 (Figure 1d).
Cells with abnormal centrosome numbers increase in
senescent MEFs. We next assessed whether there were
also changes in centrosome structure or integrity in these
cells. To test this, cells from an early passage (passage 1)
and a late senescent passage (passage 6) were stained for
centrosomal proteins. At passage 1, almost all cells
presented the expected centrosomal staining (Figure 2a
and b). NEDD1 and g-tubulin always colocalized in these
cells. However, at this passage, many cells displayed
abnormal centrosomes (Figure 2c–e). In most cases, there
was an increased number of centrosomal dots, often appearing
smaller in size than the centrosomes at passage 1, sometimes
distributed throughout the cell (Figure 2c and d) and sometimes
Figure 1 MEFs undergo senescence after 5 passages. (a) At each passage (p), cells were counted and the doubling time was calculated. The p6 cells show greatly
increaseddoubling time as cells enter senescence. (b) At each passage, the cells were analyzed for SA-b-gal staining. By passage6, the majority of cells are blue, indicating
that senescence has been activated. Scale bars¼40mm. (c) Equal amounts (50mg) of MEF protein lysates loaded onto replicate gels were analyzed by immunoblotting.
Typical markers of senescence p16, p19 and p21 are increased during passaging. (d) p21 mRNA expression in MEFs was quantitated by qPCR at passages 1, 4 and 6.
Error bars show S.E.M. (n¼3)
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Cell Death and Diseaseclustered (Figure 2e). As in early-passage cells, NEDD1 and
g-tubulin always colocalized at the centrosomes.
Quantiﬁcationofthecentrosomaldotsincellsfrompassage
1 to passage 6 indicated that there was a gradual increase in
the number of cells with more than two centrosomes from
passage 1 (1%) to passage 5 (6%), and then a greater
increaseatpassage6(16%)(Figure3a).Inthecellswithmore
than two centrosomes, the actual number of centrosomes
usually ranged from three to ﬁve; however, there was also a
proportion of cells that displayed six or more centrosomes
(Figure 3b). Although it was not feasible to costain cells for
centrosomal markers and the senescent marker SA-b-gal, it
appeared that abnormal centrosomes were occurring in
morphologically senescent cells.
The centrosomes in senescent MEFs appear to become
fragmented. It was then assessed whether the increase in
supernumerary centrosomes was due to fragmentation or
overduplication of centrosomes. To address this question,
cells at passage 1 and passage 6 were costained with
NEDD1 and the centriolar marker, GT335, which detects
glutamylated tubulin.
21 At this resolution, it was often not
possible to detect two centrioles within each centrosome;
however, at passage 1, all NEDD1 and GT335 dots
appeared normal with one to two centrosomal structures
per cell (Figure 4a and b). At passage 6, there were many
cells with more than two centrosomal structures, and they
often appeared smaller in size (Figure 4c–e). In addition,
although in most cells there was costaining of NEDD1 and
GT335 in all dots (Figure 4c and d), there were some cells
that contained dots only positive for NEDD1 and not GT335
(arrows, Figure 4e). This indicates that these dots likely
represent fragments of centrosomal material, and did not
contain an intact centriole. Although centrosome
overduplication also results in multiple centrosomes, the
smaller size and lack of complete localization of the centriole
marker within all NEDD1-immunostained dots suggests
Figure 2 Abnormal centrosome numbers in senescent MEFs. MEFs were
stained for NEDD1 (green), g-tubulin (red) and Hoechst 33342 (blue), at each
passage until senescence. The centrosomes are enlarged in the insets. Where not
obvious, the area enlarged is shown by a smaller box. (a and b) At passage 1 (p1),
most cells display normal numbers of centrosomes with either one (panel a) or 2
(panel b) centrosomes costaining with NEDD1 and g-tubulin. (c–e) By passage 6
(p6), many cells display more than two centrosomal structures either distributed
throughout the cell (panels c and d) or in close proximity to each other (panel e).
Scale bars¼20mm
Figure 3 Quantiﬁcation of abnormal centrosomes in senescent MEFs. The
numbersof centrosomesin MEFsfrompassage1 andpassage6 (examples shown
inFigure2)werecounted.Atleast300cellswerecountedforeachpassage.(a)The
percentage of MEFs with more than two centrosomes increases sharply between
passages 5 and 6. (b) Of the cells displaying more than two centrosomes, the
majority have three centrosomes, and some have four or more
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Cell Death and Diseasethat centrosome fragmentation is likely to be the
primary mechanism for the supernumerary centrosomes in
these cells.
A reduction of NEDD1 leads to premature entry into
senescence. From these experiments, it was unclear
whether centrosome disruption was a reﬂection of cells
entering senescence, or whether these changes contributed
to the fate of the cells entering senescence. To investigate
this, centrosomes were disrupted by depletion of NEDD1
using siRNA in MEFs at an early passage (passage 1). No
change was observed in NEDD1 or g-tubulin levels in control
siRNA-treated cells over the course of the experiment
(Figure 5a–c). After a double transfection of NEDD1 siRNA
over 5 days in culture, NEDD1 levels were drastically
reduced (Figure 5d and i). After removal of the siRNA at
day 5, the cells gradually regained NEDD1 expression
over 8 and 11 days after the initial siRNA transfection
(Figure 5e and f).
To investigate whether this reduction in NEDD1 could
cause premature entry of early-passage MEFs into senes-
cence, cells depleted of NEDD1 were assessed for SA-b-gal
activity on various days after NEDD1 knockdown. Cells
treated with control siRNA showed no increase in senescent
cells (o5% SA-b-gal-stained cells at each day) (Figure 5g
and h). However, cells depleted of NEDD1 showed an
increase in senescent cells 8 and 11 days after the initial
NEDD1 siRNA transfection (12 and 22% SA-b-gal-stained
cells, respectively). This was signiﬁcant at day 8 (P¼0.01),
andapproachingsigniﬁcanceatday11(P¼0.05)(Figure5h).
In addition, there was a signiﬁcant increase in the number of
senescent cells between days 5 and 11 in the NEDD1 siRNA-
treated group (P¼0.02), indicating increased senescence
over time, even when NEDD1 was becoming reexpressed in
the cells.
To further conﬁrm the induction of senescence after
centrosome disruption, cells were also depleted of Cep192,
a centrosomal protein which is a major regulator of pericen-
triolar material recruitment, centrosome maturation and
centriole duplication that has been shown to be important for
the centrosomal localization of NEDD1 and g-tubulin.
22,23 As
expected, cells treated with Cep192 siRNA with the same
conditions as for NEDD1 siRNA displayed a reduction in
NEDD1 and g-tubulin centrosomal staining, and a similar
increase in the number of senescent cells (data not shown).
A reduction of NEDD1 causes centrosome
abnormalities. Given that senescence in late-passage
MEFs was also accompanied by an increase in
supernumerary centrosomes (Figure 3), we assessed
whether the depletion of NEDD1 from early-passage MEFs
could also induce centrosome abnormalities. Depletion of
NEDD1 reduces the levels of g-tubulin at the centrosome
(Figure 5), but not the centriole marker GT335; hence,
GT335 was used for staining in these cells. Indeed, although
almost all cells in control siRNA-treated cells had one to two
centriole pairs (Figure 6a–c, each pair only visible as one
centrosomal dot), after 5 days of NEDD1 depletion, there
were many cells that showed more than two centrosomal
structures (Figure 6d). This was increased at both 8 and 11
days after initial NEDD1 depletion (Figure 6e–g). GT335-
positive dots were sometimes smaller in NEDD1-depleted
cells, suggesting that they are likely to be centrosomal
fragments. When these were quantitated, the number of cells
with more than two centrosomal structures in NEDD1-
depleted cells was increased to 28% at day 5, 38% at day
8 and to 45% at day 11 (Figure 6g). This was signiﬁcant at all
time points when compared with control-treated cells which
had B10% of cells with more than two centrosomal
structures at all days (P¼o0.05). Again, there was also a
signiﬁcant increase in the accumulation of centrosomal
structures between days 5 and 11 in the NEDD1 siRNA-
treated group (P¼0.01), indicating that centrosome
Figure 4 MEFs at passage 6 contain fragmented centrosomes. Cells were
stained for NEDD1 (green), GT335 (red) and Hoechst 33342 (blue), at passages 1
and 6. The centrosomes are enlarged in the insets. Where not obvious, the area
enlarged is shown by a smaller box. (a and b) At passage 1 (p1), most cells display
normalnumbersofcentrosomalstructureswitheither1(panela)or2(panelb)pairs
of centrioles costaining with NEDD1 and GT335. Each pair of centrioles normally
appears as a single dot at this resolution. (c–e) By passage 6 (p6), some cells
displaying more than two centrosomal structures have complete colocalization of
NEDD1 and GT335 in all centriole-like dots (panels c and d), and other cells have
some NEDD1-positive but GT335-negative dots (arrows, panel e). The dots are
often smaller in centrosomal structures at p6. Scale bars¼20mm
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Cell Death and Diseaseabnormalities increased over time, even when NEDD1 was
becoming reexpressed in the cells. Similar results were
observed for depletion of Cep192 (data not shown). These
data suggest that a loss of centrosomal integrity, caused by a
reduction in NEDD1, can lead to centrosomal abnormalities





less clear. MEFs at a late passage are a model system of
oxidative stress-induced senescence, as standard culture
Figure 5 NEDD1depletioncauses premature entryof MEFs into senescence. Passage1 MEFs weretransfected with a control (scrambled)siRNAor NEDD1 siRNAand
thenstainedforNEDD1(green)andg-tubulin(red)onday5whenthesiRNAwasremovedandagainonday8andday11.(a–c)TheMEFstransfectedwiththecontrolsiRNA
showno reductionof NEDD1 or g-tubulin protein. (d) After 5 daysof NEDD1siRNA treatment, thelevels of NEDD1and g-tubulin are dramaticallyreducedat thecentrosome.
(eandf)Thelevelsoftheseproteinsgraduallyincreases8daysaftertheinitialtransfection(3daysaftersiRNAremoval)andagain11daysaftertheinitialtransfection(6days
after siRNA removal). (g) Cells treated with the control siRNA maintain low numbers of SA-b-gal-positive cells on day 5, 8 and 11. Cells treated with NEDD1 siRNA have
relatively low levels of SA-b-gal staining after 5 days of NEDD1 depletion, but SA-b-gal-positive cells become more abundant 8 days after initial depletion, and again after 11
days.(h)ThenumberofSA-b-gal-expressingcellswascounted.Atdays8and11,thereisasigniﬁcantincreaseinthenumberofsenescentcellsintheNEDD1siRNA-treated
cellscomparedwith controlsiRNA-transfected cells.There isalso a signiﬁcantincreasein thenumberof senescentcellsbetween days5 and11 of theNEDD1siRNA-treated
group. Approximately 300 cells were counted for each group. Error bars show S.E.M. from three independent experiments. Scale bars¼40mm. (i) Immunoblotting shows
protein levels of NEDD1 in MEFs from passage 1 transfected with control (scrambled)or NEDD1siRNA for 72h, and again for another48h before harvesting.b-Actin serves
as a loading control
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Cell Death and Diseaseconditions include atmospheric (20%) oxygen which causes
DNA damage and senescence.
14 In this study, MEFs
passaged in atmospheric oxygen grew for ﬁve passages
before entry of the majority of cells into senescence. This
correlated with an increase in cell-cycle proteins p16, p19 and
p21, which are known markers of senescence in MEFs.
14
Closer analysis of senescent MEFs showed the presence of
centrosome abnormalities. At passage 6, when the majority of
cellshadenteredsenescence,manycellsdisplayedabnormal
supernumerary centrosomes. Although the percentage of
cells with supernumerary centrosomes was still relatively low
(16% at passage 6), this is likely to represent a much larger
poolof the senescent population, fortwo reasons. First, not all
cellsatpassage6werepositiveforSA-b-galactivity.Hence,a
pool of the population had not yet entered senescence.
Second, abnormal centrosomes can result in aberrant
mitoses with nonviable daughter cells,
25 and hence some of
the cells with abnormal centrosomes may have been
eliminated before analysis. This result correlates well with a
study in human Chang liver cells, which identiﬁed that 20% of
cells exposed to low doses of hydrogen peroxide, which
causes an increase in reactive oxygen species, accumulated
supernumerary centrosomes compared with 5–7% in con-
trols.
26The observation thatMEFsaccumulatesupernumerary
Figure 6 NEDD1 depletion causes abnormal centrosomes. An aliquot of cells treated with control or NEDD1 siRNA as in Figure 5 were stained for NEDD1 (green) and
GT335 (red) at day 5 when the siRNA was removed and again at days 8 and 11. (a–c) At all time points in the control (scrambled) siRNA-treated MEFs, NEDD1 and GT335
staining show normal centrioles (1–2 pairs per cell). (d) 5 days after the ﬁrst NEDD1 siRNA transfection, the level of NEDD1 is dramatically reduced at the centrosome, and
GT335stainingrevealssomecellshavemorethantwocentrosomalstructures.(eandf)At8and11daysafterNEDD1siRNAtransfection,therearemorecellswithmorethan
two centrosomal structures even though NEDD1 is becoming reexpressed. (g) The number of centrosomal structures in control scrambled siRNA-treated and NEDD1
siRNA-treated cells was quantitated. At days 5, 8 and 11, there is a signiﬁcant increase in the number of cells containing more than two centrosomal structures in the NEDD1
siRNA-treated cellscomparedwithcontrolcells.In addition,thereisa signiﬁcantincreasein thenumberof cellswithmorethantwocentrosomesbetweenday5 andday11 in
the NEDD1 siRNA-treated cells. Approximately 300 cells were counted for each group. Error bars show S.E.M. from three independent experiments. Scale bars¼40mm
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Cell Death and Diseasecentrosomes during passaging is important, as MEFs are
commonly used for many types of studies. A detailed under-
standing of the events that occur during the culture of these
cells is critical when making assumptions and interpreting
results.
Given that these MEFs were acquiring centrosome
abnormalities around the time they entered senescence, we
wantedtoassesswhethercentrosomedisruptionwasacause
or a consequence of senescence. To test this, we disrupted
the centrosome by depletion of one of its key components,
NEDD1, in healthy MEFs and assayed for the induction of
premature senescence. Indeed, after long-term NEDD1
depletion (8 days), an increase in the number of senescent
cells was observed, which continued to increase even after
NEDD1 levels had been restored. Hence, the depletion of
NEDD1 for a sustained period of time induces senescence,
most likely due to a disruption of centrosome function.
Importantly, the depletion of Cep192, which also results in a
reduction of NEDD1 and g-tubulin at the centrosome
22,23 was
also able to induce premature senescence. This provides
further evidence that disruption of the centrosome resulting in
a reduction in centrosomal NEDD1 and g-tubulin can cause
senescence.
To conﬁrm whether the reduction of NEDD1 in senescent
MEFs was also responsible for a lack of centrosome integrity
and abnormalities, centrosome integrity was evaluated in
theseMEFs depletedofNEDD1. NEDD1 depletion resultedin
an increase in the number of cells containing supernumerary
centrosomes, which were often small in size indicating
fragmented centrosomes. Given that the centrosome
abnormalities in NEDD1-depleted cells increased 5 days after
siRNA treatment, but senescent cells did not appear until day
8, it appears that centrosome fragmentation is an early event
in this process, and this then leads to the induction of
senescence. As NEDD1 is important in centriole assembly
and duplication,
16 it was expected that a reduction in NEDD1
levels may result in centrosome abnormalities due to a
reduction in the number of centrosomes, rather than the
supernumerary centrosomes observed in this study. In
addition, centrosome ampliﬁcation is commonly linked to
tumorigenesis,
27 and as such would not be expected in
senescence cells. To explain the results observed, we
hypothesized that the abnormal centrosomes in cell culture-
inducedsenescentMEFsatpassage6andNEDD1depletion-
induced senescent MEFs at an earlier passage may have
been fragmented or incorrectly assembled, rather than
overampliﬁed. In populations displaying a high proportion of
senescent cells, the centrosomal-like dots were often much
smaller than in early-passage cells. In addition, not all
NEDD1-positive dots costained for GT335, suggesting that
they contained some centriolar material that did not include
the centriole component glutamylated tubulin. Furthermore,
Cep192 is important for centriole duplication,
22,23 and hence
reduction of this protein should not allow centrosome
overduplication, even though multiple centrosome-like dots
were observed in these cells. Hence, it appears that
senescent MEFs display fragmented rather than overdupli-
cated centrosomes.
Loss of NEDD1 causing centrosome fragmentation has
also been suggested in HeLa cells.
17 This observation aligns
well with a recent study on components of the human augmin
complex (HAUS) which localizes to the centrosome and
mitotic spindle.
28 Depletion of components of the HAUS
complex causes disorganized spindles and fragmented
centrosomes.
28 Importantly, FAM29A, one of these complex
proteins, has been shown to interact with NEDD1 and recruits
this protein and therefore also g-tubulin to the centrosome and
mitotic spindle.
29 In the absence of HAUS components, the
levels of NEDD1 and g-tubulin at the centrosome are reduced,
and there is a mis-localization of motor proteins away from the
spindle.
28 The centrosomes cannot sustain the resultant
counterbalancing forces at the spindle pole and this leads to
their fragmentation. The data in our study show that the
depletion of NEDD1 in MEFs may contribute to counter-
balancing forces at the centrosome as with HAUS depletion,
which leads to centrosome fragmentation and senescence.
A functional centrosome is required for proper cell-cycle
progression.
13,24 Our study provides evidence that a loss of
centrosome integrity, which occurs in later-passage MEFs,
can result in centrosomal fragmentation and senescence. In
addition, depletion of core centrosomal proteins, such as
NEDD1, can induce premature senescence. Given that MEFs
are known to senesce as a result of oxidative stress and DNA
damage,
14 it is plausible that the oxidative stress is
responsible for centrosome disruption, possibly by causing
dysfunction of core centrosomal components such as
NEDD1, and this then, in part, leads to senescence.
Materials and Methods
Cell lines and culture. MEFs were isolated from E14.5 C57Bl/6 embryos.
30
MEFs, N18s and HeLa cells were cultured in Dulbecco’s modiﬁed Eagle’s medium
(Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (FBS)
(Invitrogen), 50Units/ml penicillin (Sigma, St. Louis, MO, USA), 0.05mg/ml
streptomycin (Sigma) at 371Ci n5 %C O 2. Other cells were retrieved from liquid
nitrogen and not cultured. Population doubling time was calculated using the
formula: ln2/(ln[A/A0])/t where A¼cell number at t¼0, A0¼initial cell number,
t¼time (hours since last passage).
Cellstaining. Cellswereplatedontoglasscoverslips24hbefore staining,ﬁxed
in 100% methanol for 5min at  201C, washed in PBS and incubated in blocking
solution (1% FBS/PBS) for 30min. Primary antibodies in blocking solution were
added for 2h at RT: 1:50 rabbit a-NEDD1,
31 1:500 mouse a-g-tubulin (GTU-88,
Sigma), 1:500 mouse a-GT335 (Gift from B Edde, CNRS, Montpellier, France) or
1:500rabbita-Cep192.
23CellswerewashedinPBSandincubatedwithsecondary
antibodies: 1:1000 rabbit Alexa Fluor 488 and/or 1:1000 mouse Alexa Fluor 568
(MolecularProbes,Invitrogen)for1hatRT.AfterwashesandstainingwithHoechst
33342 (Molecular Probes, Invitrogen) coverslips were mounted in Prolong Gold
Antifade reagent (Molecular Probes, Invitrogen). Images were obtained using a
confocal microscope (Radiance 2100, Bio-Rad Laboratories, Hercules, CA, USA)
as described previously
32 and were processed using Adobe Photoshop CS2
Version 9.0 (Adobe, San Jose, CA, USA).
b-Galactosidase staining. Cells were plated onto glass coverslips 24h
beforestaining.CellswereﬁxedandstainedusingtheSenescenceb-galactosidase
Staining Kit (Cell Signaling, Beverly, MA, USA). Cells were incubated for 24–48h at
371C before being imaged on a CKX41 microscope (Olympus, Center Valley, PA,
USA), and photographed using a DP20 camera (Olympus).
Proteinextractionandimmunoblotting. CellswerelysedinRIPAbuffer
(150mM NaCl, 1% NP-40, 0.5% DOC, 0.1% SDS, 50mM Tris pH 7.4, 5mM EDTA
and protease inhibitor cocktail solution (Roche, Mannheim, Germany)) and lysates
wereclearedbycentrifugation.Inall,50mgofproteinwasseparatedbySDS-PAGE
and transferred to PVDF membranes. Membranes were blocked in 5% skim milk
powder in PBST (0.1% Tween20/PBS) for 1–2h and incubated with primary
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Cell Death and Diseaseantibodiesovernightat41C:1:500rabbita-p16(M-156,SantaCruzBiotechnology,
SantaCruz,CA,USA),1:1000rabbita-p19(Ab80,Abcam,Cambridge,MA,USA),
1:500 mouse a-p21 (F5, Santa Cruz Biotechnology), 1:200 rabbit a-NEDD1
31 or
1:5000 a-b-actin (AC-15, Sigma). After washing in PBST, the membranes were
incubated with 1:2000 rabbit secondary ECL IgG horseradish peroxidase (HRP)-
linked whole antibody (GE Healthcare, Piscataway, NJ, USA) to detect NEDD1 or
1:2000 IgG afﬁnity isolated-alkaline phosphatase (AP) conjugated antibody
(Chemicon,Temecula,CA,USA)todetectallotherproteins,for2hatRT.Detection
of bound HRP antibody was achieved using ECL Plus (GE Healthcare) and
developed on X-ray ﬁlm (Fuji, Dusseldorf, Germany). Detection of bound AP was
achieved using ECF substrate (GE Healthcare) and developed using a Typhoon
9410 (Molecular Dynamics, Sunnyvale, CA, USA) and analyzed using ImageQuant
software (GE Healthcare).
qPCR. In all, 2mg of total RNA was used to synthesize cDNA using the High-
Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA,
USA). Samples for qPCR were prepared from this cDNA using the RT
2 SYBR
Green qPCR Master Mix (SA Biosciences, Frederick, MD, USA) according to the
manufacturers’ instructions. Primers for p21 and GAPDH mRNA expression were
as follows: QPCRmp21f: 50-AGTGTGCCGTTGTCTCTTCG-30, QPCRmp21r:
50-ACACCAGAGTGCAAGACAGC-30, GAPDHf: 50-AGACAGCCGCATCTTCTT
GT-30, GAPDHr: 50-GAATTTGCCGTGAGTGGAGT-30. Samples were run on a
Rotor Gene 6000 machine (Corbett Research, NSW, Australia) with the following
conditions: 2min at 501C, 15min at 951C, followed by 40 cycles of 951C for 15s,
601C for 25s and 721C for 10min, followed by a 3-min extension at 721C. Melt
curve was achieved by a ramp from 72 to 991C with 5s for each step. Reactions
wereperformedintriplicateandthemRNAexpressionlevelsnormalizedagainstthe
internal control gene GAPDH using the DDCT method. Data were analyzed using
the Rotor-Gene 6000 Series Software.
siRNA transfection. NEDD1 siRNAs were designed by Invitrogen to target
the following sequences: mNEDD1 siRNA no. 1: 50-GAGACAUUGUGAAUCUGC
AAGUGGA-30, mNEDD1 siRNA no. 2: 50-CCGGCACAUCAAGUACUCAUUGUUU-
30. Cep192 siRNA was designed to target the sequence 50-GGAGGACUUU
GUAAUCUCUtt-30 (GenePharma, Shanghai, China), adapted from the study by
Zhu et al.




each NEDD1 siRNA pooled, and 6ml of Cep192 siRNA or Negative Universal
Control (Medium GC). A second siRNA transfection was conducted 72h after the
ﬁrst transfection, and left for a further 48h.
Statisticalanalysis. Todeterminesigniﬁcance,atwo-tailedt-test(two-sample
assuming equal variances) was conducted. A P-value of o0.05 was considered
signiﬁcant.
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